Our SynBIOcarb ESR at Prague
F. Vena, B. Roubinet and L. Landemarre. (2022) Lectin array for quality control of recombinant biotherapeutic glycoproteins. SynBIOcarb and COST Glyconanoprobes joint conference, March 29 – April 1, 2020; Czech Academy of Sciences, Prague, Czech Republic.
In cosmetics Global – Stand P105 – Paris 5-7 April 2022
Book in your calendar!!! GLYcoDiag will be present in the next In Cosmetics global 2022 in Paris porte de Versailles from Tuesday 5th to Thursday 7th April 2022 (Stand P105). GLYcoDiag will present the full services intended to microbiote studies and its technology platform GLYcoPROFILE®, intended to the research of new active products and the study of « glyco-actives » mechanisms relevant for cosmetic applications, which allow to reduce your time development and increase your innovation capability. Contact us to book a B2B meeting with us.
GLYcoDiag’s Newsletter February 2022_Cells GLYcoPROFILE studies
GLYcoDiag’s Newsletter January 2022_Corneocytes interactions studies
GLYcoDiag’s Newsletter October 2021
Download the GLYcoDiag’s Newsletter October 2021 about Sambucus nigra agglutinin (SNA) and it added value products.
GLYcoDiag GLYcosciences Products Catalogue 2021
The Glycosciences products catalogue 2021 are now available to download.
Le projet DiagCov de GLYcoDiag soutenu par la Région Centre Val de Loire et l’Etat dans le cadre du PIA3
GLYcoPROFILE used in bacterial studies of Tropheryma whipplei infection
Divoly, A., Zarza, S. M., Landemarre, L., Roubinet, B., Decloquement, P., Raoult, D., Fournier, P.-E., Desnues, B. Human galectin-1 and galectin-3 promote Tropheryma Whipplei infection, Gut microbes, 2021, 13, e1884515 (DOI : 10.1080/19490976.2021.1884515).
GLYcoPROFILE was recently used for the characterization of Tropheryma whipplei, an actinobacterium which causes various infections in humans, including Whipple’s disease. Thus, the GLYcoPROFILE has enabled to characterize the glycan signature of T. Whipplei glycoproteins.
